Abiomed Inc
ABMD
ABMD was delisted on the 21st of December, 2022.
529 hedge funds and large institutions have $17.9B invested in Abiomed Inc in 2018 Q3 according to their latest regulatory filings, with 71 funds opening new positions, 202 increasing their positions, 184 reducing their positions, and 63 closing their positions.
13% more first-time investments, than exits
New positions opened: 71 | Existing positions closed: 63
12% more capital invested
Capital invested by funds: $16B → $17.9B (+$1.93B)
10% more repeat investments, than reductions
Existing positions increased: 202 | Existing positions reduced: 184
0% more funds holding
Funds holding: 527 → 529 (+2)
5% less funds holding in top 10
Funds holding in top 10: 21 → 20 (-1)
41% less call options, than puts
Call options by funds: $251M | Put options by funds: $424M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
+$314M |
| 2 |
JIM
Jupiter Investment Management
London,
United Kingdom
|
+$230M |
| 3 |
Sands Capital Management
Arlington,
Virginia
|
+$175M |
| 4 |
BlackRock
New York
|
+$114M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$103M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$513M |
| 2 |
Two Sigma Investments
New York
|
-$160M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$103M |
| 4 |
SI
Scout Investments
Kansas City,
Missouri
|
-$85.4M |
| 5 |
Two Sigma Advisers
New York
|
-$83.2M |
ABMD Hedge Fund Activity: Q3 2018 in Review
529 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q3 2018, worth a combined $17.9B — up 12% from $16B a quarter earlier.
Buyers outnumbered sellers: 71 funds opened new ABMD positions and 63 closed out — a net gain of 8 holders — while 202 added to existing stakes and 184 trimmed.
The largest buyer was AQR Capital Management, adding an estimated $314M. The largest seller was Baillie Gifford & Co, cutting an estimated $513M.
- 529 institutional investors held Abiomed Inc (ABMD) as of Q3 2018, up from 527 in Q2 2018.
- Funds reported $17.9B of Abiomed Inc stock for Q3 2018, up 12% quarter-over-quarter.
- 71 funds opened new Abiomed Inc positions in Q3 2018 and 63 closed out, a net change of +8 holders.
- The largest Abiomed Inc buyer in Q3 2018 was AQR Capital Management, an estimated $314M added.
- The largest Abiomed Inc seller in Q3 2018 was Baillie Gifford & Co, an estimated $513M sold.
Based on aggregated 13F filings for Q3 2018.